S
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
NV
Recent Filings
- SC 13G/A61.0 KBSEELOS THERAPEUTICS, INC.Dec 4, 1:29 PM ET·0000929638-24-004157
- 8-K208.5 KBSEELOS THERAPEUTICS, INC.Nov 22, 8:35 AM ET·0001099910-24-000383
- SC 13G/A87.9 KBSEELOS THERAPEUTICS, INC.Nov 14, 7:32 PM ET·0000929638-24-003937
- SC 13G61.0 KBSEELOS THERAPEUTICS, INC.Nov 5, 1:46 PM ET·0000929638-24-003740
- 8-K227.7 KBSEELOS THERAPEUTICS, INC.Oct 24, 4:10 PM ET·0001104659-24-111155
- 8-K214.7 KBSEELOS THERAPEUTICS, INC.Oct 15, 9:15 AM ET·0001104659-24-108396
- 8-K205.0 KBSEELOS THERAPEUTICS, INC.Oct 7, 6:07 AM ET·0001104659-24-106406
- 8-K228.3 KBSEELOS THERAPEUTICS, INC.Sep 26, 4:10 PM ET·0001104659-24-103143
- 8-K1.0 MBSEELOS THERAPEUTICS, INC.Sep 25, 8:53 AM ET·0001104659-24-102625
- S-1559.2 KBSEELOS THERAPEUTICS, INC.Sep 25, 6:09 AM ET·0001104659-24-102540
Insiders
10- ANDERSON KENNETHOfficer, (s) to Issuer
- ARMISTICE CAPITAL, LLC10% Owner
- Berholtz RandyExecutive VP & General Counsel
- BERMAN RICHARD JDirector, President and CEO
- Boyd Steven10% Owner
- Cox Edward M.VP of Corp. Development and IR
- Crea RobertoDirector
- DALESANDRO MARGARETDirector
- Damaj BassamDirector, Chief Executive Officer
- DENNER ALEXANDER J10% Owner
Tickers
No tickers on record
Addresses
business
300 PARK AVENUE 2ND FLOOR
NEW YORK, NY, 10022
mailing
300 PARK AVENUE 2ND FLOOR
NEW YORK, NY, 10022
Former Names
- APRICUS BIOSCIENCES, INC.2019-01-24
- NEXMED INC2010-09-13